Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
Radhakrishnan Ramchandren, Charles A SchifferDivision of Hematology/Oncology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USAAbstract: The development of imatinib for the treatment of chronic myeloid leukemia (CML) has proven to be an example of medical success...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-05-01
|
| Series: | Biologics : Targets & Therapy |
| Online Access: | http://www.dovepress.com/dasatinib-in-the-treatment-of-imatinib-refractory-chronic-myeloid-leuk-a3112 |